• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Phosphacyclic compounds

Research Briefing on 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one (CAS: 52500-02-4)

Recent advancements in the field of chemical biology and medicinal chemistry have highlighted the significance of phosphorus-containing heterocycles, particularly 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one (CAS: 52500-02-4). This compound, a five-membered phosphacycle, has garnered attention due to its unique structural features and potential applications in drug discovery, catalysis, and material science. This briefing synthesizes the latest research findings on this molecule, focusing on its synthesis, reactivity, and biological relevance.

A study published in the Journal of Organic Chemistry (2023) explored novel synthetic routes to 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one, emphasizing its utility as a precursor for more complex phosphorus-based scaffolds. The researchers employed a [3+2] cycloaddition strategy, achieving high yields and excellent regioselectivity. The compound's stability under physiological conditions was also investigated, suggesting its potential as a pharmacophore in medicinal chemistry applications.

Further research in ACS Medicinal Chemistry Letters (2024) investigated the biological activity of derivatives of 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one. The study identified several analogs with promising inhibitory effects against protein kinases involved in cancer progression. Molecular docking simulations revealed that the phosphol-one core interacts favorably with the ATP-binding sites of these kinases, providing a structural basis for further optimization.

In the realm of materials science, a recent publication in Advanced Materials (2024) demonstrated the use of 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one as a building block for phosphorus-doped carbon nanomaterials. These materials exhibited enhanced electrochemical properties, making them suitable for energy storage applications. The study highlighted the compound's versatility beyond traditional pharmaceutical applications.

Ongoing clinical investigations are exploring the safety profile of 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one derivatives, with preliminary results indicating acceptable toxicity levels in animal models. Researchers are particularly interested in its potential as a scaffold for neurodegenerative disease therapeutics, given its ability to cross the blood-brain barrier.

The compound's mechanism of action appears to involve modulation of cellular signaling pathways, particularly those related to oxidative stress response. This was elucidated through proteomic studies published in Cell Chemical Biology (2023), which identified several protein targets of phosphol-one derivatives in human cell lines.

Future research directions include the development of enantioselective synthesis methods for 3,4-dimethyl-2,5-dihydro-1H-1lambda5-phosphol-1-one and its chiral derivatives, as well as expanded structure-activity relationship studies to optimize its pharmacological properties. The compound's unique electronic properties also suggest potential applications in photopharmacology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)